During the past decade, Javier Sobrado, MD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Javier Sobrado, MD" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Javier Sobrado, MD" are "Ulcerative Colitis" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Javier Sobrado, MD" in a lesser frequency.

Most popular intervention types in "Javier Sobrado, MD" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Javier Sobrado, MD" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Javier Sobrado, MD". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Javier Sobrado, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Javier Sobrado, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".